Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PKM2 inhibitor is an inhibitor of pyruvate kinase M2 (PKM2; IC50 = 2.95 µM), a tumor-specific kinase with a role in glycolysis.1 It is selective for PKM2 over PKM1 and L-type pyruvate kinase (PKLR; IC50s = 16.71 and 8.2 µM, respectively). PKM2 inhibitor is cytotoxic to HCT116, HeLa, and H1299 cells (IC50s = 0.18, 0.29, and 1.56 µM, respectively). It induces apoptosis and autophagy in SKOV3 ovarian cancer cells when used at concentrations of 1, 2.5, and 5 µM.2 In vivo, PMK2 inhibitor (5 mg/kg) reduces tumor volume and weight in an SKOV3 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase. Eur. J. Med. Chem. 138, 343-352 (2017).
2. Specific Pyruvate Kinase M2 Inhibitor, Compound 3K, Induces Autophagic Cell Death through Disruption of the Glycolysis Pathway in Ovarian Cancer Cells. Int. J. Biol. Sci. 17(8), 1895-1908 (2021).